BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 23, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

March 30, 2021

View Archived Issues
Lung illustration

FDA clears Nines’ AI-based lung nodule measurement tool

Teleradiology company Nines Inc. won 510(k) clearance from the FDA for Ninesmeasure, an artificial intelligence (AI)-powered tool for measuring lung nodules. The Palo Alto, Calif.-based company says the new tool can help speed the diagnosis of certain respiratory diseases, resulting in better patient outcomes. Read More
Bag-of-euros.png

Inbrain raises $17M to bring nanoscale graphene implants to clinical development

LONDON – Inbrain Neuroelectronics Ltd. has raised €14.35 million (US$16.9 million) in a series A round to take nanoscale graphene implants it says have the potential to interface one-on-one with neurons, into clinical development later this year. The technology promises significant improvements on current implants used for deep brain stimulation to treat conditions including Parkinson’s disease, epilepsy, obsessive compulsive disorder and neuropathic pain. Read More
Device components and in use

Helius gets FDA nod for first neuromodulator for MS gait issues

The FDA authorized marketing of the Portable Neuromodulation Stimulator (Pons) for short-term treatment of gait issues arising from mild to moderate symptoms associated with multiple sclerosis (MS) through its de novo pathway. Helius Medical Inc., a subsidiary of Helius Medical Technologies Inc., makes the non-implantable neuromuscular tongue stimulator. Read More
Coronavirus vaccine, therapeutic illustration

Debate continues to boil over pandemic-related IP

The latest salvo in the debate over patents protecting COVID-19-related drugs, devices and vaccines came this week from U.S. industry organizations, including Advamed, the Biotechnology Innovation Organization and the Pharmaceutical Research and Manufacturers of America. Read More
Device image

Ferronova maps out complex cancers in sentinel lymph nodes

PERTH, Australia – Ferronova Ltd. has developed an injectable magnetic and fluorescent tracer that can map the spread of cancer in the lymph nodes more accurately for improving the staging of complex cancers. The polymer-coated iron oxide nanoparticles show more detailed assessment of sentinel lymph nodes and detect micro-metastasis and isolated tumor cells that would otherwise not be detected. Read More

Appointments and advancements for March 30, 2021

New hires and promotions in the med-tech industry, including: Aavantibio, Advanced Sterilization Products, Ceryx Medical, Dnanexus, Flatiron Health, Fortive, Paige, Rebus Biosystems, Renovacare, Zillion. Read More

Financings for March 30, 2021

Med-tech firms raising money in public or private financings, including: Augmedics, Brightinsight, Steadymd. Read More

In the clinic for March 30, 2021

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Clearflow, Instylla, Perimeter Medical Imaging AI, Pixium Vision. Read More

Other news to note for March 30, 2021

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: AI/ML Innovations, Aspect Biosystems, Beigene, Biomax Informatics, Djo Global, Genial Light, Ginkgo Bioworks, Guardant Health, Henry Schein, Hisense, IBH, Insight Medical Systems, Lantheus Holdings, JSR, Mapkure, Materials and Machines, Mimedx, Noria Therapeutics, Olive Labs, Orasure Technologies, Origo, Osang Healthcare, Personalis, Premier, Proscia, Recuro Health, Sciex, Seer, Stradis Medical, Strategic Solutions Group, Teladoc, Texcell, Think Research, Todos Medical, Toyoda Gosei, Trinity Biotech, Unilabs, Uprise, Zi Medical. Read More

Regulatory actions for March 30, 2021

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Becton Dickinson, Binx Health, Gold Standard Diagnostics, Nines. Read More

Regulatory front for March 30, 2021

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Endologix, other stent graft products in line for FDA panel safety probe; New conditions imposed on vaccine authorization; MRNA vaccine efficacy holds in real world; STIs on the rise in U.S. Read More

BioWorld MedTech’s Oncology Extra for March 30, 2021

Keeping you up to date on recent developments in oncology, including: NCI team devises method to recruit myeloid cells in pushback against cancer; Algorithm ranks cancer therapies for efficacy; New twist on quantum dots could revolutionize imaging. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 22, 2026.
  • Acid alpha-glucosidase molecular structure isolated on black

    ‘Detargeted’ targeted gene therapy improves activity in Pompe

    BioWorld
    A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 19, 2026
  • Nxera Pharma prepares and tests new GPR17 antagonists

    BioWorld Science
    Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
  • Genescience presents STAT6 degrader for atopic dermatitis

    BioWorld Science
    Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing